MALAT1 and androgen insensitivity syndrome: Our results indicated that: 1) lnc-MALAT1 expression was decreased in AIS patients compared to controls, and it had a close correlation with AIS; 2) lnc-MALAT1 high expression was correlated with decreased NIHSS score as well as reduced inflammatory factors levels in AIS patients; and 3) lnc-MALAT1 high expression showed a trend for prolonged RFS compared to lnc-MALAT1 low expression in AIS patients, but without statistical significance.